Copyright Reports & Markets. All rights reserved.

Global Liposome Assisted Drug Delivery Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Liposome Assisted Drug Delivery Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Liposomal Doxorubicin
    • 1.4.3 Liposomal Amphoteracin B
    • 1.4.4 Liposomal Paclitaxel
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Liposome Assisted Drug Delivery Market Share by Application: 2020 VS 2026
    • 1.5.2 Fungal Infection Therapy
    • 1.5.3 Cancer & Tumor Therapy
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Liposome Assisted Drug Delivery Market Perspective (2015-2026)
  • 2.2 Global Liposome Assisted Drug Delivery Growth Trends by Regions
    • 2.2.1 Liposome Assisted Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Liposome Assisted Drug Delivery Historic Market Share by Regions (2015-2020)
    • 2.2.3 Liposome Assisted Drug Delivery Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Liposome Assisted Drug Delivery Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Liposome Assisted Drug Delivery Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Liposome Assisted Drug Delivery Players by Market Size
    • 3.1.1 Global Top Liposome Assisted Drug Delivery Players by Revenue (2015-2020)
    • 3.1.2 Global Liposome Assisted Drug Delivery Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Liposome Assisted Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Liposome Assisted Drug Delivery Market Concentration Ratio
    • 3.2.1 Global Liposome Assisted Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Liposome Assisted Drug Delivery Revenue in 2019
  • 3.3 Liposome Assisted Drug Delivery Key Players Head office and Area Served
  • 3.4 Key Players Liposome Assisted Drug Delivery Product Solution and Service
  • 3.5 Date of Enter into Liposome Assisted Drug Delivery Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Liposome Assisted Drug Delivery Historic Market Size by Type (2015-2020)
  • 4.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
  • 5.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Liposome Assisted Drug Delivery Market Size (2015-2020)
  • 6.2 Liposome Assisted Drug Delivery Key Players in North America (2019-2020)
  • 6.3 North America Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
  • 6.4 North America Liposome Assisted Drug Delivery Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Liposome Assisted Drug Delivery Market Size (2015-2020)
  • 7.2 Liposome Assisted Drug Delivery Key Players in Europe (2019-2020)
  • 7.3 Europe Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
  • 7.4 Europe Liposome Assisted Drug Delivery Market Size by Application (2015-2020)

8 China

  • 8.1 China Liposome Assisted Drug Delivery Market Size (2015-2020)
  • 8.2 Liposome Assisted Drug Delivery Key Players in China (2019-2020)
  • 8.3 China Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
  • 8.4 China Liposome Assisted Drug Delivery Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Liposome Assisted Drug Delivery Market Size (2015-2020)
  • 9.2 Liposome Assisted Drug Delivery Key Players in Japan (2019-2020)
  • 9.3 Japan Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
  • 9.4 Japan Liposome Assisted Drug Delivery Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Liposome Assisted Drug Delivery Market Size (2015-2020)
  • 10.2 Liposome Assisted Drug Delivery Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Liposome Assisted Drug Delivery Market Size by Application (2015-2020)

11 India

  • 11.1 India Liposome Assisted Drug Delivery Market Size (2015-2020)
  • 11.2 Liposome Assisted Drug Delivery Key Players in India (2019-2020)
  • 11.3 India Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
  • 11.4 India Liposome Assisted Drug Delivery Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Liposome Assisted Drug Delivery Market Size (2015-2020)
  • 12.2 Liposome Assisted Drug Delivery Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
  • 12.4 Central & South America Liposome Assisted Drug Delivery Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Gilead Sciences
    • 13.1.1 Gilead Sciences Company Details
    • 13.1.2 Gilead Sciences Business Overview
    • 13.1.3 Gilead Sciences Liposome Assisted Drug Delivery Introduction
    • 13.1.4 Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2015-2020))
    • 13.1.5 Gilead Sciences Recent Development
  • 13.2 Pacira
    • 13.2.1 Pacira Company Details
    • 13.2.2 Pacira Business Overview
    • 13.2.3 Pacira Liposome Assisted Drug Delivery Introduction
    • 13.2.4 Pacira Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.2.5 Pacira Recent Development
  • 13.3 Sun Pharmaceutical
    • 13.3.1 Sun Pharmaceutical Company Details
    • 13.3.2 Sun Pharmaceutical Business Overview
    • 13.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Introduction
    • 13.3.4 Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.3.5 Sun Pharmaceutical Recent Development
  • 13.4 Johnson & Johnson
    • 13.4.1 Johnson & Johnson Company Details
    • 13.4.2 Johnson & Johnson Business Overview
    • 13.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Introduction
    • 13.4.4 Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.4.5 Johnson & Johnson Recent Development
  • 13.5 Luye Pharma
    • 13.5.1 Luye Pharma Company Details
    • 13.5.2 Luye Pharma Business Overview
    • 13.5.3 Luye Pharma Liposome Assisted Drug Delivery Introduction
    • 13.5.4 Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.5.5 Luye Pharma Recent Development
  • 13.6 Sigma-Tau Group
    • 13.6.1 Sigma-Tau Group Company Details
    • 13.6.2 Sigma-Tau Group Business Overview
    • 13.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Introduction
    • 13.6.4 Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.6.5 Sigma-Tau Group Recent Development
  • 13.7 Ipsen (Onivyde)
    • 13.7.1 Ipsen (Onivyde) Company Details
    • 13.7.2 Ipsen (Onivyde) Business Overview
    • 13.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Introduction
    • 13.7.4 Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.7.5 Ipsen (Onivyde) Recent Development
  • 13.8 CSPC
    • 13.8.1 CSPC Company Details
    • 13.8.2 CSPC Business Overview
    • 13.8.3 CSPC Liposome Assisted Drug Delivery Introduction
    • 13.8.4 CSPC Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.8.5 CSPC Recent Development
  • 13.9 Teva Pharmaceutical
    • 13.9.1 Teva Pharmaceutical Company Details
    • 13.9.2 Teva Pharmaceutical Business Overview
    • 13.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Introduction
    • 13.9.4 Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.9.5 Teva Pharmaceutical Recent Development
  • 13.10 Novartis
    • 13.10.1 Novartis Company Details
    • 13.10.2 Novartis Business Overview
    • 13.10.3 Novartis Liposome Assisted Drug Delivery Introduction
    • 13.10.4 Novartis Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 13.10.5 Novartis Recent Development
  • 13.11 Fudan-Zhangjiang
    • 10.11.1 Fudan-Zhangjiang Company Details
    • 10.11.2 Fudan-Zhangjiang Business Overview
    • 10.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Introduction
    • 10.11.4 Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
    • 10.11.5 Fudan-Zhangjiang Recent Development

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Liposome Assisted Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liposome Assisted Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Gilead Sciences
    Pacira
    Sun Pharmaceutical
    Johnson & Johnson
    Luye Pharma
    Sigma-Tau Group
    Ipsen (Onivyde)
    CSPC
    Teva Pharmaceutical
    Novartis
    Fudan-Zhangjiang

    Market segment by Type, the product can be split into
    Liposomal Doxorubicin
    Liposomal Amphoteracin B
    Liposomal Paclitaxel
    Others
    Market segment by Application, split into
    Fungal Infection Therapy
    Cancer & Tumor Therapy
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America
    Buy now